Feature Channels: Respiratory Diseases and Disorders

Filters close
Released: 9-Nov-2022 6:05 AM EST
Solutions to Tackling Smoking Rates
Rutgers University-New Brunswick

Much work needs to be done to change the United States smoking rate, Rutgers experts say on the occasion of the Great American Smokeout Nov. 17

Released: 8-Nov-2022 10:05 PM EST
Protein insights may boost lung cancer detection and treatment
University of Edinburgh

Scientists investigating the mechanics of the early stages of lung cancer have identified a new potential treatment, which could also aid early detection of the disease.

Newswise: How parents can help their kids with asthma avoid serious attacks
Released: 8-Nov-2022 4:05 PM EST
How parents can help their kids with asthma avoid serious attacks
UT Southwestern Medical Center

UTSW pediatric pulmonologist highlights how to reduce risk of serious asthma attack

Newswise: Treating parents' depression boosts treatment of children’s asthma, UTSW study finds
Released: 8-Nov-2022 3:05 PM EST
Treating parents' depression boosts treatment of children’s asthma, UTSW study finds
UT Southwestern Medical Center

Curbing depression among caregivers improves control of asthma and lung function in children

Released: 8-Nov-2022 11:30 AM EST
Researchers Develop a Risk Score to Help Detect ILD in Systemic Sclerosis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, described a first-of-its-kind validated tool to screen for systemic sclerosis-associated interstitial lung disease.

Newswise: New treatment can significantly increase the efficacy of chemotherapy and prevent metastasis
Released: 7-Nov-2022 7:55 PM EST
New treatment can significantly increase the efficacy of chemotherapy and prevent metastasis
Tel Aviv University

The researchers identified a mechanism that generated a cancer-promoting inflammatory environment in response to chemotherapy. Based on this discovery, they developed a treatment combination that reduced the incidence of lung metastasis following chemotherapy from 52% to only 6%.

Newswise: Why I’m Hopeful about Lung Cancer
Released: 7-Nov-2022 2:50 PM EST
Why I’m Hopeful about Lung Cancer
Hackensack Meridian Health

November is Lung Cancer Awareness Month, and although lung cancer is the second most common cancer in the U.S. in both men and women, and lung cancer claims more lives than other types of cancers, I am hopeful about lung cancer for many reasons.

Released: 7-Nov-2022 1:35 PM EST
Artificial intelligence could help ease hospital pressures
University of the West of Scotland

Pioneering artificial intelligence (AI) which automatically diagnoses lung diseases – such as tuberculosis and pneumonia – could ease winter pressures on hospitals, University of the West of Scotland researchers believe.

   
Released: 7-Nov-2022 8:05 AM EST
Going Beyond Lung Care for Babies With Bronchopulmonary Dysplasia
Children's Hospital Los Angeles

The Infant Chronic Lung Disease Program takes a coordinated, multidisciplinary approach to support each baby’s overall development. For Manvi Bansal, MD, one of the biggest challenges of caring for babies with severe bronchopulmonary dysplasia (BPD) is dealing with “the elephant in the room.”

Newswise: Fire in the Amazon Is Associated More with Agricultural Burning and Deforestation Than with Drought
Released: 4-Nov-2022 3:35 PM EDT
Fire in the Amazon Is Associated More with Agricultural Burning and Deforestation Than with Drought
Sao Paulo Research Foundation (FAPESP)

A Brazilian study shows that the number of fires detected in the entire Amazon region between 2003 and 2020 was influenced more by uncontrolled human use of fire than by drought.

Newswise: Organoids Reveal How SARS-CoV-2 Damages Brain Cells — and a Potential Treatment
Released: 3-Nov-2022 2:25 PM EDT
Organoids Reveal How SARS-CoV-2 Damages Brain Cells — and a Potential Treatment
University of California San Diego

Using human brain organoids, an international team of researchers has shown how the SARS-CoV-2 virus that causes COVID-19 infects cortical neurons and specifically destroys their synapses — the connections between brain cells that allow them to communicate with each other.

Released: 3-Nov-2022 1:55 PM EDT
Memorial Sloan Kettering Cancer Center Leads Collaborative Effort to End Lung Cancer Related Stigmas
Memorial Sloan Kettering Cancer Center

Stigma can have profound and lasting effects, and studies have shown that people living with lung cancer may encounter challenges in receiving the support they need from their social network and healthcare providers. Memorial Sloan Kettering Cancer Center (MSK) is committed to helping eliminate the stigmas associated with a lung cancer diagnosis and is working to raise awareness in collaboration with other national organizations.

   
Released: 2-Nov-2022 5:30 PM EDT
Nose Swabs May Distinguish Babies with RSV Needing Longer Intensive Care
Ann and Robert H. Lurie Children's Hospital of Chicago

When a child with RSV requires intensive care, parents often ask about how long it will take before their child can go home. Currently, there is no reliable way to answer this question. Results of a new study from Ann & Robert H. Lurie Children’s Hospital of Chicago, however, offer important insights.

Newswise: As respiratory illnesses increase, WVU experts share information to prevent possible ‘tridemic’
Released: 2-Nov-2022 8:05 AM EDT
As respiratory illnesses increase, WVU experts share information to prevent possible ‘tridemic’
West Virginia University

Respiratory illnesses are affected the United States as winter approaches, and a "tridemic" is possible with the flu, COVID-19 and RSV.

Released: 1-Nov-2022 10:05 AM EDT
Nation’s Top Cancer Organizations Partner to Endorse Initiative to Increase Lung Cancer Screening in the United States
Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center and Moffitt Cancer Center have partnered with more than 50 other cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose CT scans for those at high risk for lung cancer.

Released: 1-Nov-2022 9:45 AM EDT
The University of Kansas Cancer Center Partners with Nation’s Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United States
University of Kansas Cancer Center

Joint call to action urges individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer.

Newswise: Sanford Burnham Prebys Partners with Nation’s Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United States
1-Nov-2022 7:00 AM EDT
Sanford Burnham Prebys Partners with Nation’s Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United States
Sanford Burnham Prebys

Sanford Burnham Prebys has partnered with more than 50 cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose computed tomography (CT) scans for those at high risk for lung cancer.

25-Oct-2022 2:05 PM EDT
Urine bicarbonate test offers new, safe quantification of CFTR function in cystic fibrosis patients
American College of Physicians (ACP)

A study of 50 adult patients with cystic fibrosis (CF) has found that challenged urine bicarbonate excretion may offer a new, simple, and safe quantification of cystic fibrosis transmembrane conductance regulator (CFTR) function and the extent of its pharmacologic improvement. The study is published in Annals of Internal Medicine.

Newswise: Disparities in Lung Cancer Detection: Moving Toward Equity & Inclusion
Released: 31-Oct-2022 4:15 PM EDT
Disparities in Lung Cancer Detection: Moving Toward Equity & Inclusion
Rutgers Cancer Institute

According to the American Lung Association, Black Americans, Latinos, Asian Americans or Pacific Islanders and Indigenous people who are diagnosed with lung cancer face worse outcomes compared to white Americans because they are less likely to be diagnosed early. Rutgers Cancer Institute expert shares how these disparities are being addressed and where to find cancer screening resources.

Newswise: The Impact of Lung Cancer on the Hispanic Community
Released: 31-Oct-2022 3:50 PM EDT
The Impact of Lung Cancer on the Hispanic Community
Rutgers Cancer Institute

According to the 2021-2023 edition of the American Cancer Society’s Cancer Facts and Figures for Hispanic/Latino People, about 6,000 Hispanic men and 5,800 Hispanic women are expected to be diagnosed with cancer of the lung and 3,200 Hispanic men and 2,300 Hispanic women are expected to die from the disease this year. Expert from Rutgers Cancer Institute shares what the Hispanic community needs to know about the disease.

Newswise: Study Identifies Potential New Treatment Target for Sleep Apnea
Released: 31-Oct-2022 10:00 AM EDT
Study Identifies Potential New Treatment Target for Sleep Apnea
Johns Hopkins Medicine

In a new study with obese mice, Johns Hopkins Medicine researchers say they have added to evidence that specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders in obese people.

Released: 27-Oct-2022 5:45 PM EDT
‘Prime and Spike’ Nasal Vaccine Strategy Helps Combat COVID
Yale University

A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science.

Newswise: Cellular Cilium an Early Sign of Mesothelioma Differentiation
Released: 26-Oct-2022 11:00 PM EDT
Cellular Cilium an Early Sign of Mesothelioma Differentiation
Sbarro Health Research Organization (SHRO)

A new study investigated the expression of the primary cilium in mesothelioma, finding that primary cilia is preferentially lost in the more aggressive subtype of mesothelioma and further research may confirm its potential prognostic and diagnostic value.

Newswise: Dr. George Alba Announced as Latest Harold Amos Scholar in Pulmonary and Critical Care Medicine
Released: 26-Oct-2022 8:00 AM EDT
Dr. George Alba Announced as Latest Harold Amos Scholar in Pulmonary and Critical Care Medicine
American Thoracic Society (ATS)

George Alba, MD, of Massachusetts General Hospital/Harvard has been named the inaugural American Thoracic Society/American Lung Association/American College of Chest Physicians-Harold Amos Medical Faculty Development Program Scholar.

Newswise: Study Identifies Key T Cells for Immunity Against Fungal Pneumonia
Released: 25-Oct-2022 5:05 PM EDT
Study Identifies Key T Cells for Immunity Against Fungal Pneumonia
University of Illinois Urbana-Champaign

Researchers at the University of Illinois College of Veterinary Medicine have demonstrated in a mouse model that a specific type of T cell, one of the body’s potent immune defenses, produces cytokines that are necessary for the body to acquire immunity against fungal pathogens.

Newswise:Video Embedded what-parents-need-to-know-about-rsv
VIDEO
Released: 25-Oct-2022 11:30 AM EDT
What Parents Need to Know About RSV
Cedars-Sinai

Cedars-Sinai and other hospitals nationwide are seeing a surge in cases of pediatric RSV (respiratory syncytial virus) that are showing up earlier than expected this year. Healthcare providers are worried about the onset of the virus combined with the additional threats of the flu and COVID-19 as we head into winter.

11-Oct-2022 12:00 PM EDT
American Society of Anesthesiologists recognizes David O. Warner, M.D., with its Excellence in Research Award
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) today presented David O. Warner, M.D., with its 2022 Excellence in Research Award in recognition of his extensive research efforts to help improve patient care before, during and after surgery.

Released: 20-Oct-2022 5:05 PM EDT
Radon Exposure Significantly Affected by Behaviour and Socio-Economic Factors, Study Finds
University of Calgary

A new multi-disciplinary study including researchers at the University of Calgary shows that people who act quickly to test for and mitigate radon gas in their homes are at a much lower risk of developing lung cancer long-term.

Newswise: COVID-19 Medication Also Might Improve Delirium
Released: 19-Oct-2022 2:10 PM EDT
COVID-19 Medication Also Might Improve Delirium
Cedars-Sinai

Investigators from the departments of Neurology, Neurosurgery, Psychiatry, Medicine, and Biomedical Sciences at Cedars-Sinai have shown that an immune-suppressing drug similar to one used to treat severe COVID-19 reversed symptoms of delirium in mice whose lungs were injured during mechanical breathing assistance.

Released: 17-Oct-2022 2:05 PM EDT
New approach means faster understanding in public health crisis
McMaster University

The study was done for the World Health Organization (WHO) and Canadian Institutes of Health Research testing accessibility to recommendations for tuberculosis, a preventable and curable disease which is still the world’s top infectious killer. Researchers found the new approach is much more accessible, people are more satisfied and the new presentation improved the understanding of the information.

Newswise: Diversifying the next generation of TB vaccines
Released: 17-Oct-2022 1:50 PM EDT
Diversifying the next generation of TB vaccines
Texas Biomedical Research Institute

NIH’s National Institute of Allergy and Infectious Diseases awarded Texas Biomedical Research Institute and The Access to Advanced Health Institute in Seattle, Washington, a $3.5 million, five-year Innovation for Tuberculosis Vaccine Discovery grant.

Newswise:Video Embedded one-in-a-million3
VIDEO
Released: 14-Oct-2022 4:05 PM EDT
One in a Million
Cedars-Sinai

Antonia “Toni” Perez is one in a million. She’s one of 1 million patients in the U.S. who have received an organ transplant, a milestone the nation celebrated last month.

Released: 11-Oct-2022 6:30 PM EDT
The NIH/DAIDS Cross-Network (ACTG/HVTN/IMPAACT) TB Vaccine Working Group calls for people living with HIV to be included in tuberculosis vaccine development
HIV Vaccine Trials Network

People living with HIV must be included in clinical trials for new tuberculosis vaccine candidates currently in the development pipeline, say experts on an international panel convened last year to address gaps in the current TB vaccine landscape. Their recommendations appear in a new paper published today in The Lancet HIV.

Newswise: Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Released: 11-Oct-2022 4:20 PM EDT
Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Sbarro Health Research Organization (SHRO)

Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors are potentially related to adverse events in patients with metastatic Non-Small-Cell-Lung Cancer (mNSCLC).

Newswise: It’s Flu Season Again: Here’s What Cancer Patients Need to Know
Released: 11-Oct-2022 2:05 PM EDT
It’s Flu Season Again: Here’s What Cancer Patients Need to Know
Rutgers Cancer Institute

Flu season is here. Rutgers Cancer Institute expert shares what cancer patients and their families need to know.

Newswise: Phage Trial to Treat CF Patients With Multi-Drug Resistant Bacterial Infections
Released: 11-Oct-2022 11:00 AM EDT
Phage Trial to Treat CF Patients With Multi-Drug Resistant Bacterial Infections
University of California San Diego

UC San Diego scientists are leading a national early-stage clinical trial to assess the safety and efficacy of using bacteriophages to treat drug-resistant bacterial infections in cystic fibrosis patients.

4-Oct-2022 2:05 PM EDT
Most persons screened for lung cancer meet USPSTF criteria, but adherence to follow-up screening low
American College of Physicians (ACP)

A cohort study of more than one million people has found that most persons screened for lung cancer meet U.S. Preventative Services Task Force (USPSTF) criteria, but men, persons who formerly smoked, and younger eligible patients are less likely to be screened. Adherence to follow-up screening was also poor. The findings are published in Annals of Internal Medicine.

Newswise: Researchers Identify Flu-Fighting Pathways and Genes Essential for Influenza A Immune Defense
Released: 5-Oct-2022 2:15 PM EDT
Researchers Identify Flu-Fighting Pathways and Genes Essential for Influenza A Immune Defense
Mount Sinai Health System

Researchers have identified the gene TDRD7 as a key regulator against influenza A virus (IAV), which causes respiratory tract infections in 5 to 20 percent of the human population.



close
2.81669